Huna, a Brazilian healthtech, raises $1.5 million in a pre-seed round to expand its AI-powered cancer diagnostics platform. Kortex Ventures leads the round, with big_bets, Niu Ventures, New Ventures Capital, and angel investors also participating.
Researchers present a transparent AI model that uses routine complete blood count (CBC) data to pre-screen for colorectal cancer, offering a cost-effective detection approach based on standard blood-test information. The model achieves an area under the curve (AUC) of 0.77.
Huna uses artificial intelligence and routine blood tests to identify early cancer risks, beginning with breast cancer screening in Brazil. The startup is expanding its approach across Latin America.
Future Health and MIT Solve announce the global winners of a challenge. Huna applies AI to routine blood test data to identify people at elevated cancer risk earlier and guide them into appropriate screening.
A retrospective study from Brazil uses machine learning to assess breast cancer risk by identifying complex patterns in routine blood tests. The study presents complete blood count data as a risk-stratification tool for breast cancer screening, applying machine learning to information available from routine testing.